Narciso, Maristel D.

HRN: 28-75-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2026
CEFTRIAXONE 1G (VIAL)
03/24/2026
03/31/2026
IV
2g
Q24
Partial Bowel Obstruction
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: